EMILY SNYDER: Open Payments
NPI 1366834863 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,475 in 28 payments from 12 companies in 2025. Trend: 2023 $956 · 2024 $1,737 · 2025 $1,475
Food & beverage: $877Travel & lodging: $598
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $1,029 |
| W. L. Gore & Associates, Inc. | 4 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Boston Scientific Corporation | 2 | $50 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Novo Nordisk Inc | 1 | $25 |
| ABIOMED | 1 | $23 |
| Vital Connect, Inc | 1 | $20 |
| HEARTFLOW, INC. | 1 | $19 |
Products named: SYMPLICITY G3, GORE CARDIOFORM Septal Occluder, Kerendia, WATCHMAN FLX, ONPATTRO, LEQVIO, Ozempic, VITALPATCH RTM.
Industry payments across IN — which companies pay providers there.
